Overview
Acquired methemoglobinemia in critically ill patients, particularly those in intensive care units (ICUs), represents a multifaceted clinical challenge that encompasses not only respiratory and cardiovascular complications but also significant oral and ocular health issues. This condition often arises due to the complex interplay of underlying patient factors, such as the use of certain medications and compromised physiological states, exacerbated by the ICU environment. The prevalence of oral cavity disorders, including hyposalivation, mucositis, and pressure ulcers, alongside ocular complications like corneal injuries and dry eye, underscores the need for comprehensive care protocols. These issues not only affect patient comfort and quality of life but also increase the risk of secondary infections and prolonged ICU stays. Understanding the pathophysiology, epidemiology, clinical presentation, differential diagnosis, management strategies, and special considerations is crucial for effective clinical management.
Pathophysiology
Acquired methemoglobinemia in ICU patients can be intricately linked to multiple pathophysiological mechanisms, particularly those affecting mucosal health and systemic oxygenation. In intubated ICU patients, nearly absent stimulated salivary flow, as observed in a study by [PMID:12626984], leads to severe xerostomia, which parallels an increase in mucositis and oropharyngeal colonization with Gram-negative bacteria. This mechanistic link suggests that salivary insufficiency not only compromises mucosal integrity but also elevates the risk of infection, a critical concern in ICU settings where immunocompromised states are common. The compromised oral mucosa provides a fertile ground for pathogenic bacteria, potentially leading to ventilator-associated pneumonia (VAP) and other systemic infections. Additionally, the systemic effects of compromised mucosal health can indirectly influence oxygenation, as evidenced by the broader context of methemoglobinemia, where impaired oxygen delivery and utilization become significant concerns.
Epidemiology
The epidemiology of acquired methemoglobinemia and associated complications in ICU settings highlights significant variability and risk factors among critically ill patients. In Iranian ICU populations, oral cavity disorders exhibit a striking prevalence, rising from 79.7% on the third day to 90.54% by the fourth day of admission [PMID:36927446]. This rapid escalation underscores the cumulative impact of ICU interventions and prolonged immobility on mucosal health. Similarly, corneal injuries affect a substantial 59.4% of hospitalized ICU patients [PMID:36188652], reflecting the vulnerability of ocular surfaces under prolonged mechanical ventilation and sedation. Delirium, another critical issue, varies widely in incidence, ranging from 27% to 64%, indicating variability in clinical practices and the necessity for standardized assessment tools [PMID:31536628]. Notably, only 43% of patients are evaluated for pain and sedation using validated tools, and 27% for delirium, highlighting significant gaps in clinical practice that need addressing to improve patient outcomes. Hyposalivation, affecting 65% of ICU patients [PMID:40728670], further complicates these issues, as it is independently predicted by factors such as antibiotic use, nutritional therapy duration, agitation, hypotension, and albumin levels [PMID:38797947]. These findings emphasize the multifaceted nature of risk factors and the need for comprehensive monitoring and intervention strategies.
Clinical Presentation
The clinical presentation of acquired methemoglobinemia and related complications in ICU patients encompasses a spectrum of symptoms that significantly impact patient comfort and clinical outcomes. Oral health issues are prevalent, including dryness of the oral mucosa, decreased saliva flow, inflammation, dental plaque formation, gum inflammation, and accumulation of pathogenic bacteria, all of which can precipitate ventilator-dependent pneumonia [PMID:36927446]. These symptoms not only contribute to discomfort but also elevate the risk of systemic infections, particularly in a setting where immune function may be compromised. Ocular complications, such as dry eye, keratitis, conjunctivitis, and corneal abrasions, are also common [PMID:36188652], often stemming from reduced blink rates and inadequate eye care in unconscious or sedated patients. Notably, ICU patients frequently exhibit nearly absent stimulated salivary flow and elevated mucositis indices [PMID:12626984], indicating critical oral health concerns that necessitate vigilant monitoring and intervention. Additionally, oral malodour and volatile sulphur compounds (VSCs) are frequently observed and can be effectively managed through targeted oral care interventions like essential oil mouthwashes [PMID:17380550], highlighting the importance of proactive oral hygiene practices.
Differential Diagnosis
Differentiating acquired methemoglobinemia and its associated complications from other ICU-related conditions requires careful clinical assessment and consideration of specific biomarkers and clinical signs. Relative abundance of microorganisms such as Pseudomonas aeruginosa and Staphylococcus aureus correlates significantly with the severity of oral-mucosal pressure ulcers (PUs) [PMID:33691514], indicating their potential role in ulcer progression and severity. These pathogens can complicate the clinical picture by exacerbating mucositis and increasing infection risk. Additionally, distinguishing between methemoglobinemia and other forms of hypoxia or respiratory distress is crucial, as symptoms like cyanosis, dyspnea, and altered mental status can overlap. Laboratory tests, including methemoglobin levels and arterial blood gas analysis, are essential for confirming the diagnosis. Furthermore, the presence of specific risk factors, such as prolonged intubation, use of certain medications (e.g., nitrates, aniline dyes), and underlying hematological conditions, aids in narrowing down the differential diagnosis. Comprehensive evaluation integrating clinical presentation, microbiological data, and laboratory findings is key to accurate diagnosis and targeted management.
Management
Effective management of acquired methemoglobinemia and associated complications in ICU patients involves a multifaceted approach encompassing oral care, ocular protection, pain and sedation management, and preventive measures to mitigate risk factors. Oral care is paramount, given the high prevalence of hyposalivation and mucositis. Studies suggest that interventions like licorice mouthwash, known for its antibacterial and anti-inflammatory properties, can serve as a low-side-effect alternative to chlorhexidine [PMID:38867216]. However, clinicians must be cautious due to potential adverse effects of licorice, such as hypokalemia and hypertension, especially in patients with pre-existing cardiac or renal conditions. Essential oil mixtures containing tea tree, peppermint, and lemon have shown efficacy in reducing oral malodour and VSCs [PMID:17380550], underscoring the benefits of targeted oral hygiene practices. Incorporating honey into oral care routines significantly improves oral health scores [PMID:36494157], potentially reducing infection risks. Implementing structured eye care protocols is equally vital, particularly for patients with reduced consciousness levels, to prevent complications like corneal injuries and dry eye [PMID:36188652].
Pain, agitation, and delirium management require the use of validated scales such as the Numeric Rating Scale (NRS), Critical-Care Pain Observation Tool (CPOT), Richmond Agitation Sedation Scale (RASS), and Confusion Assessment Method for ICU (CAM-ICU) [PMID:31536628]. Non-benzodiazepine sedatives are recommended over midazolam to mitigate risks associated with prolonged ICU stays and delirium [PMID:31536628]. Early mobilization strategies, such as spontaneous breathing trials (SBT) and progressive mobility, are crucial for minimizing sedation levels and enhancing patient outcomes [PMID:31536628]. Early identification and management of hyposalivation are essential, as highlighted by the independent predictors identified in ICU patients, including antibiotic use, nutritional therapy duration, and hemodynamic instability [PMID:38797947]. Predictive models, such as nomograms for oral mucosal pressure injuries, can aid in identifying high-risk patients and implementing preemptive interventions [PMID:38797947]. Additionally, interventions like the Brush-Tongue-Mouth-Throat (BTMT) technique have demonstrated benefits in reducing ventilator-associated pneumonia and improving oral mucosal health [PMID:38301898].
Complications
The management of acquired methemoglobinemia and related complications in ICU patients must account for several potential complications that can significantly impact patient outcomes. Glycyrrhizin in licorice-based treatments, while beneficial for oral care, poses risks such as hypokalemia and hypertension, particularly concerning for patients with cardiac or renal conditions [PMID:38867216]. Vascular complications, including discolouration, temperature variations, capillary refill time changes, pulse fluctuations, skin ulceration, and edema, affect 9.8% of physically restrained ICU patients, with higher incidence noted in those with endotracheal tubes, lower Glasgow Coma Scale (GCS) scores, and elevated INR values [PMID:38937619]. These complications underscore the necessity for meticulous monitoring and intervention strategies to prevent skin integrity issues and systemic effects. Additionally, the persistence of oropharyngeal colonization with pathogenic microorganisms like Pseudomonas aeruginosa and Staphylococcus aureus increases the risk of secondary infections, further complicating patient recovery [PMID:12626984]. Effective oral care interventions, such as those using honey and essential oil mixtures, can mitigate these risks by improving mucosal health and reducing microbial colonization [PMID:36494157, PMID:17380550]. Regular monitoring and repositioning to alleviate mechanical pressures on oral mucosa are also critical in preventing pressure ulcers [PMID:33691514].
Special Populations
Special considerations are essential when managing ICU patients with specific vulnerabilities, such as those with cardiac, renal, or hypertensive conditions, as well as those with decreased levels of consciousness. Patients with compromised cardiac and renal function require careful monitoring when administering treatments like licorice-based mouthwashes due to potential systemic adverse effects [PMID:38867216]. In Iran, gaps in oral care practices among ICU nurses, including insufficient time, inadequate training, and discomfort with the task, highlight the need for enhanced education and support [PMID:36927446]. Patients under sedation and neuromuscular blockade are particularly susceptible to ocular complications due to compromised protective mechanisms, necessitating vigilant eye care protocols [PMID:36188652]. Tailored interventions, such as frequent repositioning and meticulous oral hygiene, are crucial for these vulnerable populations to mitigate risks associated with prolonged intubation and immobility, thereby improving overall patient outcomes and reducing complications.
Key Recommendations
References
1 Oshvandi K, Lotfi RF, Azizi A, Tapak L, Larki-Harchegani A. Comparison of the effect of licorice and chlorhexidine mouthwash on the oral health of intubated patients in the intensive care unit. BMC oral health 2024. link 2 Arkia M, Rezaei J, Salari N, Vaziri S, Abdi A. Oral status and affecting factors in Iranian ICU patients: a cross-sectional study. BMC oral health 2023. link 3 Mobarez F, Sayadi N, Jahani S, Sharhani A, Savaie M, Farrahi F. The effect of eye care protocol on the prevention of ocular surface disorders in patients admitted to intensive care unit. Journal of medicine and life 2022. link 4 Arroyo-Novoa CM, Figueroa-Ramos MI, Puntillo KA. Occurrence and Practices for Pain, Agitation, and Delirium in Intensive Care Unit Patients. Puerto Rico health sciences journal 2019. link 5 da Silva SEM, Fernandes RR, da Silva MEM, Duarte HO, da Câmara RO, de Sousa Lopes MLD et al.. Factors associated with oral candidosis and hyposalivation in intensive care unit patients: a prospective cohort study. Clinical oral investigations 2025. link 6 Yıldız İ, Özkaraman A. Vascular complications in extremities of physically restrained intensive care unit patients: A prospective, observational study. Nursing in critical care 2024. link 7 Jia L, Deng Y, Xu Y, Wu X, Liu D, Li M et al.. Development and validation of a nomogram for oral mucosal membrane pressure injuries in ICU patients: A prospective cohort study. Journal of clinical nursing 2024. link 8 Lin CC, Liaw JJ, Li CH, Chen LC, Han CY. Nurse-led intervention to improve oral mucosal health of intubated patients in the intensive care unit: A prospective study. American journal of infection control 2024. link 9 Anggraeni DT, Hayati AT, Nur'aeni A. The effect of oral care using honey as an additional topical agent on oral health status of intubated patients in the intensive care unit. Enfermeria intensiva 2022. link 10 Kim SH, Nah HS, Kim JB, Kim CH, Kim MS. Relationships Between Oral-Mucosal Pressure Ulcers, Mechanical Conditions, and Individual Susceptibility in Intubated Patients Under Intensive Care: A PCR-Based Observational Study. Biological research for nursing 2021. link 11 Hur MH, Park J, Maddock-Jennings W, Kim DO, Lee MS. Reduction of mouth malodour and volatile sulphur compounds in intensive care patients using an essential oil mouthwash. Phytotherapy research : PTR 2007. link 12 Dennesen P, van der Ven A, Vlasveld M, Lokker L, Ramsay G, Kessels A et al.. Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients. Critical care medicine 2003. link
12 papers cited of 19 indexed.